HIV plays a direct role in causing blood cell cancers in rare instances, says a new study of HIV and tumor DNA.…

The spike protein critical for coronavirus research -- and for some COVID-19 vaccines -- slowly…

All News

[Apply]
Category
Date Posted Range

Study Provides Insight into Establishment of Persistent AIDS Virus Infection; Highlights Potential Viral Vulnerability

Posted 8/6/2018
FREDERICK, Md. -- A new study led by investigators from the Frederick National Laboratory for Cancer Research in collaboration with colleagues from the Oregon Health and Science University (OHSU) utilizing a nonhuman primate model infected with Simian Immunodeficiency Virus (SIV) could have significant implications for future research into the prevention and potential cure of…

Study Provides Insight into Establishment of Persistent AIDS Virus Infection

Posted 8/6/2018
A new study led by investigators from the Frederick National Laboratory for Cancer Research in collaboration with colleagues from the Oregon Health and Science University (OHSU) utilizing a nonhuman primate model infected with Simian Immunodeficiency Virus (SIV) could have significant implications for future research into the prevention and potential cure of Human…

FNL leads interdisciplinary approach to study RAS-driven cancers

Posted 7/24/2018
Nearly one-third of all human cancers are driven by mutations in RAS genes, including almost all pancreatic cancers. Treating these cancers has puzzled scientists for decades, and many RAS proteins are considered virtually undruggable.

The Frederick National Laboratory for Cancer Research is attacking this longstanding problem from several new vantage points.…

Frederick National Laboratory Leads Interdisciplinary Approach to Study RAS-Driven Cancers

Posted 7/23/2018
FREDERICK, Md. -- Nearly one-third of all human cancers are driven by mutations in RAS genes, including almost all pancreatic cancers. Treating these cancers has puzzled scientists for decades, and many RAS proteins are considered virtually undruggable.

The Frederick National Laboratory for Cancer Research is attacking this longstanding problem from several new…

Frederick National Laboratory Leads Study to Understand Immune Response to Nanoparticles

Posted 7/11/2018
FREDERICK, Md. -- The Frederick National Laboratory for Cancer Research is opening potential new avenues for coaxing the human immune system to fight cancer and other diseases through microscopic particles, or nanoparticles.

The use of nanoparticles to transport drugs to cancer cells is a growing field that has piqued scientists’ interest over the last two…

Frederick National Laboratory, National Cancer Institute of Mexico to Offer Training Fellowships

Posted 6/26/2018
FREDERICK, Md. -- The Frederick National Laboratory for Cancer Research will extend its scientific mentoring across international borders for the first time by offering postdoctoral research fellowships to scientists under an agreement with the National Cancer Institute of Mexico (INCan).

Under a three-year Memorandum of Understanding, the two institutions will…

Frederick National Laboratory Scientists to Present Advanced Technologies in Cancer Research

Posted 6/7/2018
FREDERICK, Md. -- Hundreds of science and business professionals are expected to attend the second annual Technology Showcase at the Frederick National Laboratory for Cancer Research, scheduled for June 13.

The event will feature technologies being developed at the National Cancer Institute (NCI) and the Frederick National Laboratory to encourage startup…

Hood College, Frederick National Laboratory Will Renew Popular Scientific Symposium

Posted 5/20/2018
FREDERICK, Md. -- Hood College and the Frederick National Laboratory for Cancer Research have partnered to cohost an annual scientific symposium in the tradition of the landmark Oncogene Meeting, a national fixture in Frederick for more than 20 years.

A recently signed, three-year Memorandum of Understanding between the two institutions also will expand research…

New Nanoparticle Inhibits Growth of Pancreatic Cancer in Mice

Posted 5/9/2018
FREDERICK, Md. -- In early experiments, a targeted nanomedicine has safely halted the growth of pancreatic cancer — the deadliest of solid tumors — and prevented its most dangerous feature, metastasis, the spread of tumor cells.

Using a mouse model of the disease, scientists at Georgetown University and the Frederick National Laboratory for Cancer Research…

Numerate Intends to Join ATOM Consortium to Rapidly Accelerate Preclinical Drug Development

Posted 4/16/2018
SAN FRANCISCO – Computational drug design company Numerate has signed a letter of intent to join an open consortium of scientists staffed from two U.S. national laboratories, industry, and academia working to transform drug discovery and development into an approach that is rapid, integrated and with better patient outcomes.

Accelerating Therapeutics for…

Media Inquiries

For all media related questions please contact:

Image
A portrait photo
Mary Ellen Hackett Manager, Communications Office 301-401-8670